TNFSF13B and systemic lupus erythematosus: Patients with SLE and LN have been shown to have abnormal B-cell activation and differentiation, as well as elevated serum levels of soluble B-lymphocyte stimulator (BLyS), a key protein involved in the selection and survival of B cells [8–10].